Article
[Quantitative analysis of hepatitis B surface antigen as a clinical marker].
Rinsho byori. The Japanese journal of clinical pathology - 1 Sept 2011
Nakamura Erina, Kakuda Hirokazu, Matsuura Kentaro, Sugauchi Fuminaka, Shinkai Noboru, Tanaka Yasuhito
Abstract excerpt
There are 1.5 million hepatitis B virus (HBV) infected patients in Japan. Anti-viral therapy is important for chronic hepatitis B patients to prevent hepatocellular carcinoma. Recently, HBs antigen (HBsAg) quantification has been reported to be useful for not only HBV screening but also for monitoring of anti-viral treatment. In this paper, we evaluated the clinical utility of quantitative assay of HBsAg by HISCL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
